New head and neck cancer radiotherapy technique could deliver more robust treatment plan in shorter time on MR Linac 23 May 2022 New adaptive radiotherapy technique for head and neck cancer can deliver a more robust treatment plan in a shorter timeframe on MR Linac, compared with the current method used by most radiotherapy centres. Find out more Show/Hide
Test can personalise use of immunotherapy and chemotherapy for head and neck cancer 25 Mar 2022 Matching cancer patients to treatment based on their levels of a key immune protein may allow doctors to select those who would benefit most from the combination of immunotherapy and chemotherapy, researchers report. Find out more Show/Hide
Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers 11 Oct 2021 An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests. Find out more Show/Hide
ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’ 07 Sep 2020
ASCO 2020: New optimised precision radiotherapy can reduce swallowing difficulties for head and neck cancer patients 30 May 2020
The ICR responds to decision by NICE not to recommend pembrolizumab as first-line treatment for advanced head and neck cancer 15 Jan 2020
Major trial backs immunotherapy as standard first-line treatment for head and neck cancer 23 Nov 2019
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer 04 Jun 2019
ESMO 2018: Immunotherapy effective as first-line treatment for advanced head and neck cancer 22 Oct 2018